Kerr, S, Bedston, S, Bradley, D T, Joy, M, Lowthian, E, Mulholland, R M, Akbari, A, Hobbs, F D R, Katikireddi, S V, de Lusignan, S, Rudan, I, Torabi, F, Tsang, R S M, Lyons, R A, Robertson, C & Sheikh, A 2023, ' Waning of first-and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales ', International Journal of Epidemiology, vol. 52, no. 1, pp. 22–31 . https://doi.org/10.1093/ije/dyac199 Kerr, S, Bedston, S, Bradley, D T, Joy, M, Lowthian, E, Mulholland, R M, Akbari, A, Hobbs, F D R, Katikireddi, S V, de Lusignan, S, Rudan, I, Torabi, F, Tsang, R S M, Lyons, R A, Robertson, C & Sheikh, A 2022, ' Waning of first-and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations : a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales ', International Journal of Epidemiology . https://doi.org/10.1093/ije/dyac199
Bedston, S, Lowthian, E, Jarvis, C I, Akbari, A, Beggs, J, Bradley, D, de Lusignan, S, Griffiths, R, Herbert, L, Hobbs, R, Kerr, S, Lyons, J, Midgley, W, Owen, R K, Quint, J K, Tsang, R, Torabi, F, Sheikh, A & Lyons, R A 2023, ' COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales : A national prospective cohort study ', Vaccine, vol. 41, no. 7, pp. 1378-1389 . https://doi.org/10.1016/j.vaccine.2023.01.023 Bedston, S, Lowthian, E, Jarvis, C I, Akbari, A, Beggs, J, Bradley, D, de Lusignan, S, Griffiths, R, Herbert, L, Hobbs, R, Kerr, S, Lyons, J, Midgley, W, Owen, R K, Quint, J K, Tsang, R, Torabi, F, Sheikh, A & Lyons, R A 2023, ' COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study ', Vaccine, vol. 41, no. 7, pp. 1378-1389 . https://doi.org/10.1016/j.vaccine.2023.01.023
Agrawal, U, Bedston, S, McCowan, C, Oke, J, Patterson, L, Robertson, C, Akbari, A, Azcoaga-Lorenzo, A, Bradley, D T, Fagbamigbe, A F, Grange, Z, Hall, E C R, Joy, M, Katikireddi, S V, Kerr, S, Ritchie, L, Murphy, S, Owen, R K, Rudan, I, Shah, S A, Simpson, C R, Torabi, F, Tsang, R S M, Lusignan, S D, Lyons, R A, O'Reilly, D & Sheikh, A 2022, ' Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales ', The Lancet, vol. 400, no. 10360, pp. 1305-1320 . https://doi.org/10.1016/S0140-6736(22)01656-7 Agrawal, U, Bedston, S, McCowan, C, Oke, J, Patterson, L, Robertson, C, Akbari, A, Azcoaga-Lorenzo, A, Bradley, D T, Fagbamigbe, A F, Grange, Z, Hall, E C R, Joy, M, Katikireddi, S V, Kerr, S, Ritchie, L, Murphy, S, Owen, R K, Rudan, I, Shah, S A, Simpson, C R, Torabi, F, Tsang, R S M, de Lusignan, S, Lyons, R A, O'Reilly, D & Sheikh, A 2022, ' Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters : pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales ', The Lancet, vol. 400, no. 10360, pp. 1305-1320 . https://doi.org/10.1016/S0140-6736(22)01656-7